Actinium Pharmaceuticals (ATNM)
(Real Time Quote from BATS)
$6.95 USD
-0.30 (-4.14%)
Updated Apr 18, 2024 01:08 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.42 | 0.00% |
Earnings Summary
For their last quarter, Actinium Pharmaceuticals (ATNM) reported earnings of -$0.33 per share, beating the Zacks Consensus Estimate of $-0.54 per share. This reflects a positive earnings surprise of 38.89%. Look out for ATNM's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year increase of 2.33%.
Earnings History
Price & Consensus
Zacks News for ATNM
Finch Therapeutics Group, Inc. (FNCH) Reports Q3 Loss, Misses Revenue Estimates
ATNM: What are Zacks experts saying now?
Zacks Private Portfolio Services